Clinical AI company Sensyne Health has announced plans to explore a dual listing on NASDAQ. The company, which was founded by former science minister and CEO Lord Paul Drayson and listed on AIM in 2018, said the dual listing was among a number of options being considered as it continued to explore strategic growth opportunities…